SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.33-0.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (3516)4/21/2001 5:30:47 PM
From: scaram(o)uche  Read Replies (1) of 52153
 
George:

She must have some smarts since she is in agreement with you on at least something.

You continue to misrepresent my opinion of XOMA. There is no malice, so I do not get upset.

XOMA has wasted more money than any other biotech that I can think of. IMO, most of the waste was predictable and predicted. In that sense and IMO, it was actually a sin. The exploration of CD11a-specific biologicals is clearly not a waste.

Integrins/selectins were formally proposed as a focal point for XOMA's research program in *1986*, after company representatives met with Mike Gallatin at University of Washington.............

icos.com

This chart pattern, IMO, has derived from truth issues, bait and switch tactics, and a lack of biologic insight........

quote.yahoo.com

I have often stated that (1) Dellio et al. can put product into a vial and clinicals as well as anyone, and (2) Costello seems to be doing a good job.

Everything that I've predicted about evolution of the XOMA business plan and equity structure has come to pass. The days where I can make such predictions about the company are gone, as I don't follow them closely.

Biologic insight now appears to be driven by Genentech and Onyx. I wish you good luck in *all* of your investments.

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext